Standard & Poor's
http://www2.standardandpoors.comStandard & Poor’s, a division of McGraw-Hill (NYSE: MHP), produces financial research and analysis on stocks and bonds. It provides credit ratings on public and private corporations and is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) by the SEC. The firm’s long-term credit ratings range from “AAA” to “D” and its short-term credit ratings range from “A-1” to “D”. Standard & Poor’s also publishes indexes including the S&P 500.
View Older Stories
-
Omega's 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More...)
-
Mylan (MYL) PT Raised to $45 at RBC Capital; Positive Near-Term on Stock
-
Omega Advisors 13F Shows New Stake in Humana (HUM), Wells Fargo (WFC), Gold ETF (GLD), Sells AET (AET) (More...)
-
Maverick Capital's 13F Shows New Stakes in Dow (DOW), MGM (MGM), Molson (TAP) (more...)
-
Appaloosa Management's 13F Shows New Stakes in Southwestern Energy (SWN), Chesapeake Energy (CHK), Alibaba (BABA), Increase in Western Digital (WDC), Decrease in GM (GM) (more...)
-
Maverick's 13F Shows New Stakes in Envision (EVHC), Walgreens (WBA), Increase in Inbev (BUD), Tesoro (TSO) (More...)
-
Tepper's Appaloosa 13F Shows New Stake in Bank of America (BAC), Increase in GM (GM), Arcelor Mittal (MT), Southwest Airlines (LUV), (More...)
-
Pre-Open Stock Movers 03/01: (CLNE) (DVAX) (LOW) Higher; (PANW) (ENPH) (SRPT) Lower (more...)
-
Tepper's Appaloosa Enters American Airlines (AAL), Micron (MU), JC Penney (JCP), Pfizer (PFE) (more...) - 13F
-
Maverick Capital Enters Martin Marietta (MLM), Raises Adobe (ADBE), Raises Aetna (AET) (more...) - 13F
-
Maverick Capital 13F Shows New Stakes in Blue Buffalo Pet (BUFF), Dollar General (DG), Increase in ABI (BUD), Philip Morris (PM), (More...)
-
Pre-Open Stock Movers 08/10: (CLNE) (OCN) (HRTX) (YELP) Higher; (GEVO) (SPWR) (MYGN) (PRGO) Lower (more...)
-
After-Hours Stock Movers 08/09: (CLNE) (OCN) (YELP) Higher; (GEVO) (SPWR) (MYGN) Lower (more...)
-
Sachem Head Capital Shows New Stakes in Endo (ENDP), SBA Comm (SBAC) (more...) - 13F
-
Tepper's Appaloosa Enters BofA (BAC), Facebook (FB), Twenty-First Century Fox (FOXA) (more...)
-
Appaloosa Management's 13F Shows New Stakes in Abengoa Yield (ABY), Community Health (CYH), Energy Transfer (ETP), Freeport-McMoran (FCX) ...
-
S&P Affirms Ratings on Mylan (MYL) Following Meda AB Acquisition Announcement
-
Buy Apple (AAPL) Options Ahead of Catalysts - Goldman Sachs
-
Eton Park Enters CIGNA (CI), Sherwin-Williams (SHW), Raises Adobe (ADBE) (more...)
-
Tepper's Appaloosa 13F Shows New Stake in Southwest Airlines (LUV), Increase in NXP Semi (NXPI), Lower Stake in Apple (AAPL) (more...)
-
Pre-Open Stock Movers 11/13: (LPCN) (PLNT) (MYL) Higher; (VIPS) (JWN) (FOSL) Lower (more...)
-
Perrigo (PRGO) Reaffirms View, Calls Mylan's (MYL) Tactics 'Desperate'
-
S&P Assigns 'BBB' Corp. Rating to Mylan (MYL); Places on CreditWatch Negative
-
Perrigo (PRGO) Issues Response to 'Misleading' Mylan (MYL) Letter
-
Tepper's Appaloosa Shows New Stake in Alibaba (BABA), Apple (AAPL), Raises BofA (BAC), (more...)
-
Eton Park Enters Adobe (ADBE), Catamaran (CRTX), Raises Microsoft (MSFT) Sharply
-
Market Wrap: Initial Claims Rose Less than Expected; Merger Thursday; Planet Fitness IPO Ends Flat
-
Teva Pharma (TEVA) Ratings Cut to 'BBB+' by S&P; Remains on CreditWatch Negative
-
Pre-Open Stock Movers 07/27: (MAG) (TEVA) (AGN) Higher; (BLPH) (MYL) (GRUB) Lower (more...)
-
Wall Street drops as China stock slump stokes growth fears
-
Market Wrap: Fed Keeps Rate Hike in Sights; Q1 GDP Growth Lags Views; The Teva/Perrigo/Mylan Shuffle Continues
-
Teva Pharma (TEVA) Sends Letter to Mylan (MYL); Aims to Address Merger Concerns
-
Market Wrap: Apple Does it Again in Q2; Mylan Rejects Teva Bid; Applied Materials, Tokyo Electron Terminate Merger
-
Mylan (MYL) Rejects Unsolicited Teva (TEVA) Proposal
-
Top 10 News for 4/20 - 4/24: Comcast Cancels Time Warner Deal; Teva/Mylan/Perrigo Saga Continues; Big Names, Solid Earnings
-
Market Wrap: Teva Makes it Official with Mylan; DuPont Warns on FX Impact; Yahoo!'s Display Revenue Struggle Continues
-
Mylan (MYL) Ratings Placed on CreditWatch Negative by S&P Following Bid to Acquire Perrigo (PRGO)
-
S&P Affirms Mylan (MYL) at 'BBB-'; Business Risk Profile 'Satisfactory'
-
Guggenheim Names Top 2015 Picks in Specialty Pharmaceuticals; Sees Continued M&A (VRX) (ZTS) (NEOT)
-
Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results
-
Market Wrap: BofA Rethinks Capital Plan; Two Mergers Dematerialize; Alstom Attracts Siemens Eye
-
Mylan (MYL) Will Have $3B in 'Firepower' by Year-End, Says Goldman Sachs
-
Notable 52-Week Highs and Lows of the Day 11/12: (GILD) (TSM) (MYL) High; (JCP) (STSI) (LNET) Low
-
Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings
-
Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's
-
Barclays 2012 Top Picks: Becoming Somewhat More Optimistic - Signs of Progress, Growth and Soft Landings
-
Daily State of the Markets 09/23: Shoulda, Coulda, Woulda?
-
David Moenning's Daily State of the Markets: 3/13
-
Citi Initiates Coverage on Mylan (MYL) with a Buy

